Listen to the most interesting reporting from this week in the world of business, finance, tech, and politics. Over the weekend, we'll share a mix of …
452 clip(s)
Loading playlist
The shape-shifting telehealth company has spent the past year trying to cash in on GLP-1s, the hottest drug to hit weight loss in decades. It could all slip away. By Madison Muller and Devin Leonard